Rhythm Pharmaceuticals Reacquires Imcivree® Rights in China
21 Mar 2025 //
GLOBENEWSWIRE
China NMPA approves RareStone`s pitolisant for the treatment of narcolepsy
04 Jul 2023 //
PR NEWSWIRE
21 Mar 2025 //
GLOBENEWSWIRE
04 Jul 2023 //
PR NEWSWIRE